Ascentage Pharma Group International (AAPG) Receivables (2023 - 2025)
Historic Receivables for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $10.8 million.
- Ascentage Pharma Group International's Receivables changed N/A to $10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is 4241.31% down from last year.
- According to the latest figures from Q2 2025, Ascentage Pharma Group International's Receivables is $10.8 million.
- Ascentage Pharma Group International's 5-year Receivables high stood at $21.2 million for Q4 2023, and its period low was $10.8 million during Q2 2025.
- Its 3-year average for Receivables is $14.8 million, with a median of $12.4 million in 2024.
- Data for Ascentage Pharma Group International's Receivables shows a peak YoY increase of 4132.89% (in 2024) and a maximum YoY decrease of 4132.89% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Receivables stood at $21.2 million in 2023, then tumbled by 41.33% to $12.4 million in 2024, then dropped by 12.84% to $10.8 million in 2025.
- Its Receivables was $10.8 million in Q2 2025, compared to $12.4 million in Q4 2024 and $21.2 million in Q4 2023.